HESI Pharmacology Final Exam 2025
Potassium chloride intravenously is prescribed for a client with hypokalemia. Which
actions should the nurse take to plan for preparation and administration of the
potassium? Select all that apply.
1. Obtain an intravenous (IV) infusion pump.
2. Monitor urine output during administration.
3. Prepare the medication for bolus administration.
4. Monitor the IV site for signs of infiltration or phlebitis.
5. Ensure that the medication is diluted in the appropriate volume of fluid.
6. Ensure that the bag is labeled so that it reads the volume of potassium in the
solution. - -1, 2, 4, 5, and 6
Rationale: Potassium chloride administered intravenously must always be diluted in IV
fluid and infused via an infusion pump. Potassium chloride is never given by bolus (IV
push). Giving potassium chloride by IV push can result in cardiac arrest. The nurse
should ensure that the potassium is diluted in the appropriate amount of diluent or fluid.
The IV bag containing the potassium chloride should always be labeled with the volume
of potassium it contains. The IV site is monitored closely because potassium chloride is
irritating to the veins and there is risk of phlebitis. In addition, the nurse should monitor
for infiltration. The nurse monitors urinary output during administration and contacts the
health care provider if the urinary output is less than 30 mL/hour.
Salicylic acid is prescribed for a client with a diagnosis of psoriasis. The nurse monitors
the client, knowing that which finding indicates the presence of systemic toxicity from
this medication?
Tinnitus
Diarrhea
Constipation
Decreased respirations - -Tinnitus
Rationale: Salicylic acid is absorbed readily through the skin, and systemic toxicity
(salicylism) can result. Symptoms include tinnitus, dizziness, hyperpnea, and
psychological disturbances. Constipation and diarrhea are not associated with
salicylism.
Silver sulfadiazine is prescribed for a client with a burn injury. Which laboratory finding
requires the need for follow-upby the nurse?
HESI
, HESI
1. Glucose level of 99 mg/dL (5.65 mmol/L)
2. Magnesium level of 1.5 mEq/L (0.75 mmol/L)
3. Platelet level of 300,000 mm3 (300 × 109/L)
4. White blood cell count of 3000 mm3 (3.0 × 109/L) - -White blood cell count of 3000
mm3 (3.0 × 109/L)
Rationale: Silver sulfadiazine is used for the treatment of burn injuries. Adverse effects
of this medication include rash and itching, blue-green or gray skin discoloration,
leukopenia, and interstitial nephritis. The nurse should monitor a complete blood count,
particularly the white blood cells, frequently for the client taking this medication. If
leukopenia develops, the health care provider is notified and the medication is usually
discontinued. The white blood cell count noted in option 4 is indicative of leukopenia.
The other laboratory values are not specific to this medication, and are also within
normal limits.
A burn client is receiving treatments of topical mafenide acetate to the site of injury. The
nurse monitors the client, knowing that which finding indicates that a systemic effect has
occurred?
Hyperventilation
Elevated blood pressure
Local rash at the burn site
Local pain at the burn site - -Hyperventilation
Rationale: Mafenide acetate is a carbonic anhydrase inhibitor and can suppress renal
excretion of acid, thereby causing acidosis. Clients receiving this treatment should be
monitored for signs of an acid-base imbalance (hyperventilation). If this occurs, the
medication will probably be discontinued for 1 to 2 days. Options 3 and 4 describe local
rather than systemic effects. An elevated blood pressure may be expected from the pain
that occurs with a burn injury.
Isotretinoin is prescribed for a client with severe acne. Before the administration of this
medication, the nurse anticipates that which laboratory test will be prescribed?
Potassium level
Triglyceride level
Hemoglobin A1C
Total cholesterol level - -Triglyceride level
Rationale: Isotretinoin can elevate triglyceride levels. Blood triglyceride levels should be
measured before treatment and periodically thereafter until the effect on the
HESI